Dr Squatch Was Built to Be Acquired
The Dr Squatch acquisition by Unilever in 2025 was not a surprise to anyone who had been watching the brand closely. It was the logical conclusion of a go-to-market strategy built from day one around a very specific kind of value creation: own a category position so clearly that a larger player eventually has to pay for it rather than compete with it.
That is a different ambition from building a brand people love. It requires a different set of decisions, made earlier, with more commercial discipline than most founder-led brands manage to apply.
Key Takeaways
- Dr Squatch built acquisition value by owning a category position, not just a product. The brand stood for something specific enough that Unilever could not easily replicate it without buying it.
- The brand’s growth was driven by upper-funnel creative investment at a time when most DTC competitors were optimising lower-funnel performance. That asymmetry created a durable advantage.
- Influencer and creator distribution was not a campaign tactic for Dr Squatch. It was the primary go-to-market channel, structured to reach audiences who had never considered the category before.
- Acquirers pay premiums for brands with defensible positioning and loyal audiences. Dr Squatch had both, which is why the deal happened on founder-favourable terms.
- The acquisition playbook is reproducible, but it requires founders and CMOs to make brand-building decisions that look expensive in year two and look brilliant in year six.
In This Article
What Actually Happened With the Dr Squatch Acquisition
Dr Squatch was founded in 2013 by Jack Haldrup. The brand sold natural bar soap positioned specifically at men, a demographic that had been almost entirely ignored by the personal care category. For the first several years it was a small DTC operation with a niche following. Then the brand made a series of go-to-market decisions that compounded over time into something much more valuable.
The most important of those decisions was the 2019 YouTube ad. A long-form creative piece, unpolished by traditional standards, that leaned into humour and spoke directly to men who found mainstream personal care brands either irrelevant or vaguely emasculating. The ad went viral not because it was clever in an advertising sense, but because it said something true to an audience that had not been spoken to before. It reached new audiences rather than capturing existing intent, and that distinction matters enormously.
I spent a long time earlier in my career overvaluing lower-funnel performance. It looks efficient on a dashboard. Cost per acquisition is clean, attributable, easy to defend in a board meeting. What I eventually understood, after managing significant ad spend across multiple categories, is that much of what performance marketing gets credited for was going to happen anyway. The person who already knew what they wanted, already had purchase intent, would have found the product through some channel. The real growth question is: who have you reached who would never have found you otherwise? Dr Squatch answered that question with creative, not with targeting.
If you want more context on how this kind of thinking applies to go-to-market strategy more broadly, the Go-To-Market & Growth Strategy hub covers the commercial frameworks behind brand-led growth in depth.
Why Unilever Bought Dr Squatch Instead of Building a Competitor
Large FMCG companies have enormous distribution networks, manufacturing scale, and procurement advantages. What they consistently struggle to build from scratch is authentic brand positioning in categories where consumer trust is earned through culture rather than shelf placement.
Unilever could have launched a men’s natural soap brand. They have done exactly that kind of thing before. The problem is that a Unilever-owned men’s natural soap brand would have been immediately legible as a corporate response to a trend, and the audience Dr Squatch had built was precisely the kind of audience that would have seen through it. Brand equity in this space is not transferable from a parent company. It has to be earned by the brand itself, over time, through consistent positioning.
This is the commercial logic behind acquisition premiums in the DTC space. Acquirers are not buying products. They are buying audiences, and more specifically, they are buying the relationship between a brand and an audience that cannot be replicated quickly or cheaply. BCG’s work on commercial transformation makes the point that sustainable growth comes from building genuine category positions, not from optimising existing ones. Dr Squatch had done the former.
The men’s personal care category is also genuinely large and growing. Unilever’s existing portfolio in this space, brands like Dove Men+Care and Axe, skewed either toward mass market positioning or toward a younger demographic. Dr Squatch gave them a credible entry into a premium, values-led segment they did not otherwise own. That strategic gap is what made the acquisition make sense beyond the brand’s standalone revenue.
The Go-To-Market Strategy That Made the Brand Acquirable
Dr Squatch’s go-to-market approach had three elements that, taken together, created the acquisition value Unilever eventually paid for.
The first was category creation rather than category entry. The brand did not position itself as a better version of existing men’s soap. It positioned itself as the antidote to everything wrong with the category, which is a much more defensible place to stand. When you define the category, competitors have to define themselves in relation to you. That is a structural advantage that compounds over time.
The second was creative investment at the top of the funnel when the competitive pressure was almost entirely at the bottom. Most DTC brands in 2019 and 2020 were competing on Facebook and Instagram performance ads, optimising CPAs, and building businesses that were essentially renting their audiences from Meta. Dr Squatch put serious money into long-form YouTube content that built brand awareness rather than capturing existing search demand. The short-term efficiency metrics were worse. The long-term brand equity was incomparably better.
The third was creator and influencer distribution built as a channel, not a campaign. Creator-led go-to-market strategies have become more common since, but Dr Squatch was doing this systematically before it was a standard playbook. They identified creators whose audiences overlapped with their target demographic and built ongoing relationships rather than one-off sponsored posts. The result was sustained reach into new audiences rather than repeated exposure to existing customers.
I think about this in terms of something I observed running retail clients years ago. A customer who walks into a clothes shop and tries something on is many times more likely to buy than one who just browses. The act of engagement creates purchase intent that did not exist before. Dr Squatch’s creative approach did the same thing at scale: it created intent in people who had no prior interest in premium men’s soap. That is genuinely hard to do, and it is the thing performance marketing cannot replicate.
What the Acquisition Tells Us About DTC Brand Building
There is a version of the Dr Squatch story that gets told as a social media success story, a viral ad story, or a DTC disruption story. All of those framings miss the more interesting point.
The brand was built to be acquired. Not in a cynical sense, but in the sense that every significant go-to-market decision it made increased the strategic value of the brand to a potential acquirer. Clear positioning that a large company could not replicate. A loyal audience with genuine emotional attachment. A creative voice that would be destroyed by corporate interference. Distribution through channels that required cultural credibility to work.
These are not accidents. They are the result of a founder and leadership team making decisions that prioritised long-term brand equity over short-term performance metrics. That trade-off is genuinely difficult to make when you are a growing business with investors expecting quarterly progress. Most brands do not make it. Dr Squatch did, consistently, over several years.
Forrester’s intelligent growth model describes this kind of compounding brand investment as the difference between brands that grow and brands that scale. Growing brands add revenue. Scaling brands build the structural conditions that make revenue defensible. Dr Squatch scaled in that sense long before the acquisition conversation started.
I have judged the Effie Awards, which means I have spent time evaluating campaigns specifically on the basis of business effectiveness rather than creative quality. The campaigns that consistently win are not the most creative or the most innovative. They are the ones where the strategic logic is clear, the audience insight is specific, and the execution is consistent over time. Dr Squatch’s go-to-market approach would score well on all three of those criteria, which is a more useful way to think about it than simply saying the ads were funny.
The Risk Unilever Is Taking On
Acquisitions of brand-led DTC businesses have a mixed track record inside large FMCG companies. The strategic logic is usually sound. The execution is where things go wrong.
The risk for Unilever is straightforward: the thing that made Dr Squatch valuable is the thing most at risk from corporate ownership. The brand’s voice is irreverent, specific, and culturally legible to its audience. The moment it starts to sound like a Unilever brand, the audience will notice. The creator relationships that drive distribution depend on those creators believing in the brand. The moment the brand’s authenticity becomes questionable, those relationships become transactional, and transactional creator relationships do not generate the same kind of reach.
Unilever’s track record with acquired brands is actually better than many of its competitors. The Ben & Jerry’s model, where the acquired brand retains significant operational independence and cultural autonomy, has been influential across the industry. If Unilever applies a similar approach to Dr Squatch, the acquisition could work well. If they apply standard FMCG brand management processes to a brand that was built on the opposite of standard FMCG brand management, they will destroy the value they paid for.
BCG’s research on scaling agile organisations is relevant here. The structural challenge is not just cultural. It is operational. Dr Squatch was built to move quickly, test creative, and respond to audience signals. Integrating that into a large corporate structure without losing the speed and responsiveness that made it work is a genuine management challenge, not just a branding one.
What Marketers Should Take From This
The Dr Squatch acquisition is a useful case study for any marketer thinking about brand-led growth, but the lesson is not “make funny YouTube ads and get acquired.” The lesson is more specific and more demanding than that.
Category positioning is a strategic choice, not a creative output. Dr Squatch did not stumble into owning the men’s natural personal care space. The brand made deliberate decisions about what it stood for and what it explicitly rejected, and it held those positions consistently even when the short-term commercial pressure was to broaden the appeal and capture more of the market.
Audience ownership matters more than channel efficiency. The brands that end up being acquired at a premium are the ones with audiences that cannot be easily reached through other means. Building that kind of audience requires investing in channels and creative approaches that build genuine connection, not just conversion. Vidyard’s research on pipeline development points to the same underlying dynamic in B2B contexts: the brands with the most defensible pipeline are the ones that have invested in reaching audiences before those audiences are in market.
Long-term brand investment requires institutional courage. Early in my career, I was in a brainstorm for a major drinks brand. The founder had to leave the room and handed me the whiteboard pen. The instinct in that moment, when you are suddenly responsible for the direction of a room, is to play it safe. To say something defensible rather than something true. The brands that build real equity are the ones where someone, at some point, said the true thing instead of the defensible thing. Dr Squatch’s creative approach required exactly that kind of courage, repeatedly, over several years.
Understanding how to build go-to-market strategies that create this kind of compounding value is something I cover across the growth strategy section of The Marketing Juice. The commercial frameworks behind acquisition-ready brand building are not complicated, but they do require a different set of priorities than most marketing teams are currently optimising for.
The final point is about measurement. Dr Squatch made investments in brand awareness and creative quality that would have looked inefficient on a last-click attribution model. The YouTube ad that drove the brand’s growth would have generated almost no directly attributable revenue in the short term. A marketing team optimising for performance metrics would have cut the budget. The Dr Squatch team understood that growth loops require investment in stages that do not immediately convert, and they had the commercial discipline to hold that position.
That is the real lesson from the acquisition. Not the tactics. The discipline.
About the Author
Keith Lacy is a marketing strategist and former agency CEO with 20+ years of experience across agency leadership, performance marketing, and commercial strategy. He writes The Marketing Juice to cut through the noise and share what works.
